NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,413 | -61.3% | 68,610 | -6.4% | 0.00% | – |
| Q2 2023 | $189,821 | -25.9% | 73,290 | +16.7% | 0.00% | – |
| Q1 2023 | $256,224 | -14.2% | 62,800 | +5.5% | 0.00% | – |
| Q4 2022 | $298,690 | -40.9% | 59,500 | +54.1% | 0.00% | – |
| Q3 2022 | $505,000 | +2.0% | 38,600 | 0.0% | 0.00% | – |
| Q2 2022 | $495,000 | +17.3% | 38,600 | +39.4% | 0.00% | – |
| Q1 2022 | $422,000 | -19.5% | 27,700 | -6.4% | 0.00% | – |
| Q4 2021 | $524,000 | -65.2% | 29,600 | -58.6% | 0.00% | -100.0% |
| Q3 2021 | $1,505,000 | +110.2% | 71,576 | +97.2% | 0.00% | – |
| Q2 2021 | $716,000 | -0.3% | 36,300 | +47.0% | 0.00% | – |
| Q1 2021 | $718,000 | -20.5% | 24,700 | -17.1% | 0.00% | – |
| Q4 2020 | $903,000 | +82.1% | 29,800 | -4.5% | 0.00% | – |
| Q3 2020 | $496,000 | -22.7% | 31,200 | -4.0% | 0.00% | – |
| Q2 2020 | $642,000 | +95.1% | 32,500 | +21.7% | 0.00% | – |
| Q1 2020 | $329,000 | +21.0% | 26,700 | +81.6% | 0.00% | – |
| Q4 2019 | $272,000 | +50.3% | 14,700 | +12.2% | 0.00% | – |
| Q3 2019 | $181,000 | – | 13,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |